Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

08 July 2026

Op-ed: The Trillion-Dollar Opportunity: Turning the Tide on Maternal and Child Health

In an op-ed for India Health Fund, Jayasree K. Iyer, CEO of the Access to Medicine Foundation, outlines why investing in women’s and children’s health in low- and middle-income countries is both a moral imperative and a major economic opportunity.

Direct links

Read the full op-ed

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, explains how improving access to healthcare products for women and children can deliver benefits across generations. She cites research estimating that closing the women’s health gap could add USD 1 trillion to the global economy each year by 2040. 

In the op-ed, Jayasree highlights the scale of the challenge in low- and middle-income countries, where products to manage health conditions and prevent avoidable deaths exist but still need to be scaled up. She notes how persistent gaps in delivery systems and product availability, alongside uneven access to essential healthcare products, continue to drive preventable harm for women and children. 

She outlines ways to bridge the gap between innovation and delivery, from initiatives to expand access to diagnostics and treatments to market-shaping tools such as volume guarantees that can support more reliable supply. Jayasree concludes that progress depends on accountability, shared best practices and ensuring existing solutions reach those who need them most. 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

In the media

Media

Op-ed: When Geopolitics Meets Pharmaceuticals, Global Health Pays the Price

30 April 2026
Media

Op-ed: How AI can help bridge healthcare gaps worldwide

17 February 2026
Media

Op-ed: Smart policies, not more dependence, will boost Africa’s health financing

12 November 2025

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved